Although the frequency of PTEN loss in patients with prostate cancer varies between studies, largely owing to differences in the methodological approaches used, recent studies involving large prostate cancer patient cohorts have indicated that PTEN is lost in approximately 15–20% of primary prostate cancers [2,3,4,5]. Here, PTEN is linked to prostate carcinoma.